IMC Chicago’s 10x Genomics TXG Stock Holding History

IMC Chicago’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,257	Closed	-$662K	–	6822
2026 Q1	$536K	Buy	25,257 +9,123	+57%	+$182K	﹤0.01%	3969
2025 Q4	$263K	Buy	+16,134	New	+$244K	﹤0.01%	3877

Other funds holding TXG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

IMC Chicago's TXG Position: Q2 2026 in Review

IMC Chicago sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 25,257 shares — an estimated $662K sold.

IMC Chicago first reported a position in TXG in Q4 2025 and held it in 2 quarters. The position peaked at $536K in Q1 2026. 157 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

IMC Chicago reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 25,257 10x Genomics shares in Q2 2026, an estimated $662K.
IMC Chicago first reported a position in 10x Genomics in Q4 2025 and held it in 2 quarters.
IMC Chicago's 10x Genomics position peaked at $536K in Q1 2026.
157 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.